-
From Bharathi Vennapusa on November 22nd, 2020
0 likes 3 playsVENTANA PD-L1 (SP142) IHC assay is FDA-approved for mTNBC. Test for PD-L1 to identify patients who could benefit from TECENTRIQ + nab-pac in 1L mTNBC* This video is… -
From Bharathi Vennapusa on November 19th, 2020
0 likes 0 playsBrief video on scoring algorithm for VENTANA HER2 Dual ISH DNA Probe Cocktail. Content and approvals of any product related information is current as of the date of… -
From Bharathi Vennapusa on December 4th, 2020
0 likes 3 playsBrief video on scoring algorithm for VENTANA HER2 Dual ISH DNA Probe Cocktail. Content and approvals of any product related information is current as of the date of… -
From Bharathi Vennapusa on March 15th, 2021
0 likes 0 playsAn overview of validation and verification of IHC in vitro diagnostic assays. TE-US-00990 -
From Denise Croix on February 15th, 2021
0 likes 3 playsDr. Linda Ahn from Roche Medical and Scientific Affairs team discusses the current standard of care in cervical cancer screening. Part 1 of a 4 part series. Content… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 3 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses the tumor microenvironment, the cancer… -
From Bharathi Vennapusa on January 14th, 2021
0 likes 7 playsRecording for Dr. Lawrence Weiss's talk on CAP Today Webinar from December 1, 2020. Title: Tracking TRK with IHC: Today’s Diagnostic Algorithms for NTRK… -
From Bharathi Vennapusa on January 29th, 2021
0 likes 1 playsIn this short video, Roche Pathologist, Michael Lynch, M.D. reviews the scoring method for the VENTANA HER2 Dual ISH assay as well as discusses scoring challenges and… -
From Bharathi Vennapusa on December 2nd, 2020
0 likes 3 playsThis video is an explainer of the recent relaxation of FDA and CMS guidance on digital pathology during the COVID19 pandemic. Roche Medical and Scientific Affairs… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 4 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses: 1. SP142 assay is optimized for… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 2 playsVENTANA PD-L1 (SP142) assay is the first and only FDA-approved assay for mTNBC*. Testing for PD-L1 identifies patients who could benefit from TECENTRIQ + nab-pac in… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 7 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses on: 1. The PD-L1 biomarker and its… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 8 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses: 1. How and why PD-L1 is present on… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 8 playsDr. Bharathi Vennapusa from Roche MSA discusses Pan-TRK IHC using VENTANA pan-TRK (EPR17341) Assay. Content and approvals of any product related info is current as of… -
From Bharathi Vennapusa on January 31st, 2021
1 likes 6 playsDrs. Bharathi Vennapusa, Denise Croix and Katie Robertson discuss overview of NTRK fusions, testing methods, algorithms with a focus on pan-TRK IHC assay using VENTANA…
Search for ""
Public, Open and Moderated
- Managers:
- Appears In: